Buy Versartis Stock | VSAR Stock Price & Latest News | Public.com

VSAR

Versartis

$0.00 (0.00%)Today

    About VSAR

    Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion prote...Read more

    Community

    People who own or watch this stock

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Price Targets

    What analysts think this stock will be worth

    $11.61
    current
    $0.00
    average

    Stats

    Market Cap$185,64M
    Volume8,91k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.62
    1 Year Low$3.34
    Open$11.44
    High$11.94
    Low$11.10

    Buy any stock with any amount of money.

    Download the App
    Download the app